ID: ALA2282821

Max Phase: Preclinical

Molecular Formula: C12H8Cl2N4

Molecular Weight: 279.13

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  ClCc1nc(Cl)c2cnn(-c3ccccc3)c2n1

Standard InChI:  InChI=1S/C12H8Cl2N4/c13-6-10-16-11(14)9-7-15-18(12(9)17-10)8-4-2-1-3-5-8/h1-5,7H,6H2

Standard InChI Key:  ZOANCJOAKNNRRG-UHFFFAOYSA-N

Associated Targets(Human)

G-361 890 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 279.13Molecular Weight (Monoisotopic): 278.0126AlogP: 3.21#Rotatable Bonds: 2
Polar Surface Area: 43.60Molecular Species: NEUTRALHBA: 4HBD: 0
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 0.18CX LogP: 3.43CX LogD: 3.43
Aromatic Rings: 3Heavy Atoms: 18QED Weighted: 0.53Np Likeness Score: -2.06

References

1. Devarakonda M, Doonaboina R, Vanga S, Vemu J, Boni S, Mailavaram RP.  (2013)  Synthesis of novel 2-alkyl-4-substituted-amino-pyrazolo[3,4-d]pyrimidines as new leads for anti-bacterial and anti-cancer activity,  22  (3): [10.1007/s00044-012-0084-0]

Source